glp-1 news A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the latest JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD FDA warns Novo Nordisk of

Thymosin Alpha-1 and Immune Function Thymosin alpha-1 has the most robust human evidence in this category, though most of it comes from infectious disease and oncology contexts, not longevity per se

My appetite is in control (no midday snacking for this gal!), no side effects, I've been regular and not constipated like I was on Ozempic, and I've also noted my skin is looking better probably due to less stomach inflammation

However, anti-apoptotic responses to exendin-phe1 were no greater than for unmodified exendin-4 (Supplementary Fig

Healthy, natural foods are encouraged, not only from the standpoint of interactions with these medications, but for whole body wellness